US rights have zero value without FDA approval. Insto’s won’t buy in unless there is FDA approval. That’s the catch 22 Oncosil finds itself in.
The entire company can be bought for a little over$10 million. That’s a couple of houses in Sydney (Eastern suburbs).
The company at one stage had a market cap of over $100 million. That’s when cap raises or partnerships should have been pursued.
Not sure what can be done now.
US rights have zero value without FDA approval. Insto’s won’t...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.000(0.00%) |
Mkt cap ! $14.43M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 294 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 27 | 1 |
View Market Depth
| Last trade - 07.04am 19/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |
Day chart unavailable